Peripheral Lung Squamous Carcinoma With ROS1 Rearrangement Sensitive to Crizotinib: A Case Report

ROS1 rearrangements have been identified as driver mutations, accounting for 1–2% of lung adenocarcinoma, but are extremely rare in case of lung squamous cell carcinoma. In this work, we report a lung squamous cell carcinoma in a patient with peripheral lung cancer radiological manifestation, harbor...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Oncol
Hoofdauteurs: Yang, Guangdie, Wang, Jie, Yao, Yinan, Zhao, Jun, Yu, Zheyan, Gao, Qiqi, Ye, Jiani, Ma, Wenjiang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2021
Onderwerpen:
Oncology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256165/
https://ncbi.nlm.nih.gov/pubmed/34235088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.703318
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items